Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make the difference in their everyday lives.
Shield Therapeutics is a commercial stage, pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru®
Find out moreAccrufer®/Feraccru® is a novel oral product that addresses the needs of patients who cannot tolerate existing oral iron products and offers a clear alternative to IV iron therapy.
Find out moreThe content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.
Today we celebrate #nursesday2022 and say thank you to all the amazing nurses across the world. A big thank you fr… https://t.co/shTKjUinGE
We are delighted to share that Fabiana Lacerca-Allen, our Non Executive Director has been showcased as one of… https://t.co/dxVWWaXLNK
